AMGN vs UDR · P/E 24, rev $10.05B vs P/E 26, rev $1.71B
Amgen Inc (AMGN) versus UDR Inc (UDR) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
UDR Inc (UDR) is a reit - residential company listed on NYSE.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported UDR revenue for 2025-12-31 was $1.71B. Net income was $377.7M. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
Not investment advice. Open the AMGN and UDR stock pages for the full models.
Not investment advice.